title: Fifth biannual report of the Cochrane Haematologic Malignancies Group--Focus on multiple myeloma.
authors.affiliation: Cochrane Haematological Malignancies Group, Cologne, Germany. frauke.naumann@uk-koeln.de
authors.forename: Frauke
authors.initials: F
authors.lastname: Naumann
authors.forename: Olaf
authors.initials: O
authors.lastname: Weingart
authors.forename: Eva
authors.initials: E
authors.lastname: Kruse
authors.forename: Holger
authors.initials: H
authors.lastname: Schulz
authors.forename: Julia
authors.initials: J
authors.lastname: Bohlius
authors.forename: Helge
authors.initials: H
authors.lastname: Hülsewede
authors.forename: Andreas
authors.initials: A
authors.lastname: Engert
mesh_terms: D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects / Q000627:therapeutic use*; D006689:Hodgkin Disease / Q000188:drug therapy; D006801:Humans; D015451:Leukemia, Lymphocytic, Chronic, B-Cell / Q000188:drug therapy; D008228:Lymphoma, Non-Hodgkin / Q000188:drug therapy; D015337:Multicenter Studies as Topic; D009101:Multiple Myeloma / Q000188:drug therapy*; D011446:Prospective Studies; D016032:Randomized Controlled Trials as Topic